4.5 Article

Detection of a divergent Parainfluenza 4 virus in an adult patient with influenza like illness using next-generation sequencing

期刊

BMC INFECTIOUS DISEASES
卷 14, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1471-2334-14-275

关键词

Parainfluenza 4; Community infection; Respiratory tract infection; Influenza like illness; Next generation sequencing; Virus discovery; PCR; False negative results; Adult

资金

  1. NIH [U54 AI057160]
  2. ARC Linkage Grant [LP0989464]
  3. QCMRI Program [50006]
  4. QCMRI Early Career Research Fellowship [50056]
  5. Australian Research Council [LP0989464] Funding Source: Australian Research Council

向作者/读者索取更多资源

Background: Human Parainfluenza viruses are a common cause of both upper and lower respiratory tract infections, particularly in children. Of the four Parainfluenza virus serotypes, Parainfluenza 4 is least well characterised from both the clinical, epidemiological and genetic perspectives. Methods: Flocked nose or throat swabs from a previous study investigating viral prevalence in community-based adults suffering from influenza like illness were used as the basis for this study. Samples in which no virus was detected using a 16 viral respiratory pathogen real-time PCR panel were barcoded and pyrosequenced using the Roche 454 GS FLX Titanium chemistry. The sequences were analysed using the VirusHunter bioinformatic pipeline. Sanger sequencing was used to complete the detected Parainfluenza 4 coding region. Results: A variant Parainfluenza 4 subtype b strain (QLD-01) was discovered in an otherwise healthy adult who presented with influenza like illness. Strain QLD-01 shared genomic similarities with both a and b subtypes. The extent of divergence of this genome from the 5 available whole Parainfluenza 4 genomes impacted the predicted binding efficiencies of the majority of published Parainfluenza 4 PCR assays. Conclusions: These findings further support a possible role for Parainfluenza 4 in the aetiology of adult respiratory disease within the community setting, and highlight the caution needed to be used in designing PCR assays from limited sequence information or in using proprietary commercial PCR assays.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据